Top

Published in:

01-02-2014 | Research Article

Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer

Authors: Zhe Wang, Xu Chen, Bo Liu, Shide Li, Mingjun Liu, Hong Xue

Published in: Tumor Biology | Issue 2/2014

Abstract

Gastric cancer is one of the most prevalent types of cancer in the world today. Recently, there is a large sample volume of published case–control studies on XRCC3 Thr241Met polymorphism with gastric cancer. This will have an important impact on published article by meta-analysis regarding XRCC3 Thr241Met polymorphism with gastric cancer. Therefore, it is necessary to update by meta-analysis to comprehensively investigate the relationship between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer. To preciously examine the association between the XRCC3 Thr241Met polymorphism and gastric cancer, we undertook a meta-analysis of 12 case–control studies. The association between the XRCC3 Thr241Met polymorphism and gastric cancer risk was assessed by odds ratios together with their 95 % confidence intervals using a fixed-effects model or random-effects model. We found that the XRCC3 Thr241Met polymorphism was not associated with an increased gastric cancer risk. However, the XRCC3 Thr241Met polymorphism was associated with decreased gastric cancer risk in Asians. In addition, there is no evidence of association on XRCC3 Thr241Met polymorphism with response to chemotherapy and prognosis in gastric cancer. The XRCC3 Thr241Met polymorphism might influence gastric cancer risk in Asians.

Guo R, Guo X. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk. Tumour Biol. 2012;33(4):1125–32. doi:10.1007/s13277-012-0353-z.PubMedCrossRef

Sameer AS. Colorectal cancer: a researcher's perspective of the molecular angel's gone eccentric in the Vale of Kashmir. Tumour Biol. 2013;34(3):1301–15. doi:10.1007/s13277-013-0692-4.PubMedCrossRef

Wang Z, Zhang W. Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk. Tumour Biol. 2013;34(3):1421–9. doi:10.1007/s13277-012-0639-1.PubMedCrossRef

Yin QH, Liu C, Li L, Zu XY, Wang YJ. Association between the XRCC3 T241M polymorphism and head and neck cancer susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev. 2012;13(10):5201–5.PubMedCrossRef

Xu YH, Gu LP, Sun YJ, Cheng BJ, Lu S. No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis. Tumour Biol. 2013;34(2):865–74. doi:10.1007/s13277-012-0619-5.PubMedCrossRef

Zhao L, Long XD, Yao JG, Wang C, Ma Y, Huang YZ, et al. Genetic polymorphism of XRCC3 codon 241 and Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi Population, China: a hospital-based case-control study. Cancer Epidemiol. 2011;35(6):564–8. doi:10.1016/j.canep.2011.03.004.PubMedCrossRef

Fang F, Wang J, Yao L, Yu XJ, Yu L. Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis. Med Oncol. 2011;28(4):999–1003. doi:10.1007/s12032-010-9591-3.PubMedCrossRef

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.PubMedCrossRef

Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–48.PubMed

10.

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58. doi:10.1002/sim.1186.PubMedCrossRef

11.

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557.PubMedCrossRef

12.

Attia J, Thakkinstian A, D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol. 2003;56(4):297–303.PubMedCrossRef

13.

Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedCrossRef

14.

Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316(7129):469. author reply 70-71.PubMedCrossRef

15.

Ruzzo A, Canestrari E, Maltese P, Pizzagalli F, Graziano F, Santini D, et al. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin Chem Lab Med. 2007;45(7):822–88. doi:10.1515/CCLM.2007.143.PubMedCrossRef

16.

Palli D, Polidoro S, D'Errico M, Saieva C, Guarrera S, Calcagnile AS, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis. 2010;25(6):569–75. doi:10.1093/mutage/geq042.PubMedCrossRef

17.

Canbay E, Agachan B, Gulluoglu M, Isbir T, Balik E, Yamaner S, et al. Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res. 2010;30(4):1359–64.PubMed

18.

Shen H, Wang X, Hu Z, Zhang Z, Xu Y, Hu X, et al. Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population. Cancer Lett. 2004;206(1):51–8. doi:10.1016/j.canlet.2003.09.003.PubMedCrossRef

19.

Huang GP, Zheng ZL, Cai L. DNA repair gene XRCC3 Thr241Met polymorphism and susceptibility to cardia and non-cardia gastric cancer: a case-control study. Zhonghua Liu Xing Bing Xue Za Zhi. 2006;27(5):420–3.PubMed

20.

Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11(42):6593–600.PubMed

21.

Ye W, Kumar R, Bacova G, Lagergren J, Hemminki K, Nyren O. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis. 2006;27(9):1835–41. doi:10.1093/carcin/bgl017.PubMedCrossRef

22.

Huang WY, Chow WH, Rothman N, Lissowska J, Llaca V, Yeager M, et al. Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis. 2005;26(8):1354–9. doi:10.1093/carcin/bgi084.PubMedCrossRef

23.

Ruzzo A, Graziano F, Kawakami K, Watanabe G, Santini D, Catalano V, et al. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy. J Clin Oncol. 2006;24(12):1883–91. doi:10.1200/JCO.2005.04.8322.PubMedCrossRef

24.

Shim HJ, Yun JY, Hwang JE, Bae WK, Cho SH, Lee JH, et al. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin. Cancer Sci. 2010;101(5):1247–54. doi:10.1111/j.1349-7006.2010.01514.x.PubMedCrossRef

25.

Ott K, Rachakonda PS, Panzram B, Keller G, Lordick F, Becker K, et al. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy. Ann Surg Oncol. 2011;18(9):2688–98. doi:10.1245/s10434-011-1601-y.PubMedCrossRef

26.

Lin J, Kou Y. Association between the Thr241Met polymorphism of X-ray repair cross-complementing group 3 gene and glioma risk: evidence from a meta-analysis based on 4,136 cases and 5,233 controls. Tumour Biol. 2013. doi:10.1007/s13277-013-1059-6.

27.

Xu Z, Shi R, Zhang R, Zhang D, Wang L. Association between tumor necrosis factor beta 252 A/G polymorphism and risk of gastric cancer: a meta-analysis. Tumour Biol. 2013. doi:10.1007/s13277-013-0989-3.

28.

Yu JY, Li L, Ma H, Liu K, Cheng X, Li YL, et al. Tumor necrosis factor-alpha 238 G/A polymorphism and gastric cancer risk: a meta-analysis. Tumour Biol. 2013. doi:10.1007/s13277-013-0972-z.

29.

Lv L, Wang P, Sun B, Chen G. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer. Tumour Biol. 2013. doi:10.1007/s13277-013-1028-0.

30.

Cen G, Wu W. Association between tumor necrosis factor-alpha 857C/T polymorphism and gastric cancer: a meta-analysis. Tumour Biol. 2013. doi:10.1007/s13277-013-0910-0.PubMed

31.

Malik MA, Gupta A, Zargar SA, Mittal B. Role of genetic variants of deleted in colorectal carcinoma (DCC) polymorphisms and esophageal and gastric cancers risk in Kashmir Valley and meta-analysis. Tumour Biol. 2013. doi:10.1007/s13277-013-0870-4.PubMed

32.

Wu Z, Wang H, Chu X, Chen J, Fang S. Association between FAS-1377 G/A polymorphism and susceptibility to gastric cancer: evidence from a meta-analysis. Tumour Biol. 2013;34(4):2147–52. doi:10.1007/s13277-013-0747-6.PubMedCrossRef

33.

Tian X, Tian Y, Ma P, Sui CG, Meng FD, Li Y, et al. Association between MDM2 SNP309 T > G and risk of gastric cancer: a meta-analysis. Asian Pac J Cancer Prev. 2013;14(3):1925–9.PubMedCrossRef

34.

Ke P, Wu ZD, Wen HS, Ying MX, Long HC, Qing LG. Current evidence on associations between the MMP-7 (-181A > G) polymorphism and digestive system cancer risk. Asian Pac J Cancer Prev. 2013;14(4):2269–72.PubMedCrossRef

35.

Zhu CL, Huang Q, Liu CH, Lin XS, Xie F, Shao F. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis. Asian Pac J Cancer Prev. 2013;14(4):2349–54.PubMedCrossRef

36.

Wu D, Jiang H, Yu H, Xu D, Liang J, Jin J. Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis. Tumour Biol. 2013. doi:10.1007/s13277-013-0973-y.PubMedCentral

37.

Duan C, Zhang W, Lu J, Wu H, Liu M, Zhu W. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk. Tumour Biol. 2013. doi:10.1007/s13277-013-0841-9.

38.

Jiang J, Quan XF, Zhang L, Wang YC. The XRCC3 Thr241Met polymorphism influences glioma Risk–a meta-analysis. Asian Pac J Cancer Prev. 2013;14(5):3169–73.PubMedCrossRef

39.

Tian X, Tian Y, Ma P, Sui C, Meng F, Li Y, et al. Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population. Tumour Biol. 2013. doi:10.1007/s13277-013-0806-z.

Title: Quantitative assessment of the associations between DNA repair gene XRCC3 Thr241Met polymorphism and gastric cancer
Authors: Zhe Wang
Xu Chen
Bo Liu
Shide Li
Mingjun Liu
Hong Xue
Publication date: 01-02-2014
Publisher: Springer Netherlands
Published in: Tumor Biology / Issue 2/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-013-1219-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population

The association between the Arg280His polymorphism in the XRCC1 gene and the risk of hematological malignancies

Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics

Quantitative assessment of the association between XPG Asp1104His polymorphism and bladder cancer risk

Association between XRCC3 Thr241Met polymorphism and risk of brain tumors: a meta-analysis

Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer?

Keynote webinar | Spotlight on antibody–drug conjugates in cancer